Pui Yee Ng

9 Patents

• US124798072025

  Methods Using HDAC11 Inhibitors

  VALO HEALTH, Inc.

  0 cites
• US123049042025

  Bicyclic [4,6,0] Hydroxamic Acids as HDAC Inhibitors

  VALO HEALTH, Inc.

  0 cites
• US122641372025

  3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids as HDAC Inhibitors

  VALO HEALTH, Inc.

  0 cites
• US122139692025

  2-spiro-5- and 6-hydroxamic Acid Indanes as HDAC Inhibitors

  VALO HEALTH, Inc.

  0 cites
• US121628882024

  Carboxamides as Ubiquitin-specific Protease Inhibitors

  Valo Health, Inc.

  0 cites
• US119198392024

  Alpha-cinnamide Compounds and Compositions as HDAC8 Inhibitors

  VALO HEALTH, Inc.

  0 cites
• US118913652024

  3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids as HDAC Inhibitors

  VALO HEALTH, Inc.

  0 cites
• US117307212023

  2-spiro-5- and 6-hydroxamic Acid Indanes as HDAC Inhibitors

  Valo Health, Inc.

  0 cites
• US117024122023

  Bicyclic [4,6,0] Hydroxamic Acids as HDAC Inhibitors

  Valo Health, Inc.

  0 cites